DHR

Danaher Corporation
$234.09
+9.85 (+4.39%)
Mkt Cap 164.56B
Volume 8,794,481
52W Range 160.93-242.8
Sector Healthcare
Beta 0.80
EPS (TTM) 6.12 USD
P/E Ratio 38.25
Revenue (TTM) 25.61B USD
Rev Growth (5Y) +2.0%
EPS Growth (5Y) +0.4%
AlphaVal · Fair Value
What we estimate one share is worth
$95.70
Overvalued strong signal
144.6% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C+
Stable Earnings Power
59.8 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 24.57B 23.88B 23.89B 26.64B 29.45B 22.28B 17.91B 17.05B 18.33B 16.88B 14.43B 19.91B
Net Income 3.61B 3.90B 4.76B 7.21B 6.43B 3.65B 2.56B 2.65B 2.49B 2.55B 2.60B 2.60B
EPS 5.07 5.33 6.44 9.80 8.77 4.97 3.48 3.78 3.58 3.69 4.81 3.70
Free Cash Flow 5.26B 5.30B 5.78B 7.37B 7.06B 5.42B 3.32B 3.44B 2.91B 2.93B 3.29B 3.29B
FCF / Share 7.44 7.24 7.85 10.16 9.89 7.67 4.64 4.91 4.18 4.24 4.71 4.69
Operating CF 6.42B 6.69B 7.16B 8.52B 8.36B 6.21B 3.95B 4.02B 3.48B 3.52B 3.80B 3.76B
Total Assets 83.46B 77.54B 84.49B 84.35B 83.18B 76.16B 62.08B 47.83B 46.65B 45.30B 48.22B 36.99B
Total Debt 18.42B 17.15B 19.54B 20.62B 23.27B 22.18B 22.53B 9.74B 10.52B 12.27B 12.87B 3.47B
Cash & Equiv 4.62B 2.08B 5.86B 6.00B 2.59B 6.04B 19.91B 787.80M 630.30M 963.70M 790.80M 3.01B
Book Value 52.53B 49.54B 53.49B 50.08B 45.17B 39.77B 30.27B 28.21B 26.36B 23.00B 23.69B 23.38B
Return on Equity 0.07 0.08 0.09 0.14 0.14 0.09 0.08 0.09 0.09 0.11 0.11 0.11
DHR News
Why Danaher Stock Bounced Higher Today
Oct 21, 2026 01:06 PM · fool.com
Danaher Corporation (DHR) Q3 2026 Earnings Call Transcript
Oct 21, 2026 11:44 AM · seekingalpha.com
Danaher: 3 Key Takeaways for Long-Term Investors
Oct 21, 2026 10:20 AM · fool.com
Danaher Corp (DHR) (Q3 2026) Earnings Call Highlights: Core Growth Accelerates to 5.5% Ex-Respiratory as EPS Guidance Rises
Oct 21, 2026 10:01 AM · gurufocus.com
Danaher Q3 Review: Interested To See What The New Management Will Bring
Oct 21, 2026 09:12 AM · seekingalpha.com
DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line
Oct 21, 2026 07:46 AM · zacks.com
Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves
Oct 21, 2026 07:24 AM · benzinga.com
Danaher Q3 Earnings Call Highlights
Oct 21, 2026 07:04 AM · marketbeat.com
Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say
Oct 21, 2026 06:31 AM · zacks.com
Danaher (DHR) Tops Q3 Earnings and Revenue Estimates
Oct 21, 2026 04:26 AM · zacks.com